Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial‐mesenchymal transformation in a mouse model of myocarditis. (3rd November 2020)
- Record Type:
- Journal Article
- Title:
- Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial‐mesenchymal transformation in a mouse model of myocarditis. (3rd November 2020)
- Main Title:
- Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial‐mesenchymal transformation in a mouse model of myocarditis
- Authors:
- Fang, Yan
Chang, Zhitang
Xu, Zhicheng
Hu, Jing
Zhou, Haiwen
Yu, Songping
Wan, Xuan - Abstract:
- Abstract: Osteoglycin (Ogn), a class III SLRP member with multiple glycosylation sites, has been proposed to be engaged in cardiac dysfunction and adverse remodeling in human heart failure following myocardial infarction. However, the underlying mechanism remains to be elucidated. Thus, we sought to define the role of Ogn in regulation of the Wnt pathway on myocardial fibrosis and epithelial/endothelial‐mesenchymal transformation (EMT/EndMT) in mice with myocarditis. The pathological changes are observed, while hematoxylin–eosin staining and picric acid Sirius red staining were conducted in successfully constructed myocarditis mouse models. Immunohistochemistry and enzyme‐linked immunosorbent assay were adopted to determine Ogn and β‐catenin levels and serum procollagen propeptide concentrations in the mouse myocardial tissues, respectively. Expression of Ogn and Wnt signaling pathway‐related factors were measured by reverse transcription quantitative polymerase chain reaction and western blot assay, cell viability by 3‐(4, 5‐Dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide assay, and cell cycle distribution and apoptosis by flow cytometry. We saw indicative pathological changes accompanied by many Ogn and β‐catenin positive cells and increased serum procollagen propeptide, in the mouse myocardial tissues. Loss function assays showed reduced levels of Ogn, β‐catenin, LRP6, TGF‐β1, Twist, FSP‐1, α‐SMA and higher levels of E‐cadherin and VE‐cadherin, together withAbstract: Osteoglycin (Ogn), a class III SLRP member with multiple glycosylation sites, has been proposed to be engaged in cardiac dysfunction and adverse remodeling in human heart failure following myocardial infarction. However, the underlying mechanism remains to be elucidated. Thus, we sought to define the role of Ogn in regulation of the Wnt pathway on myocardial fibrosis and epithelial/endothelial‐mesenchymal transformation (EMT/EndMT) in mice with myocarditis. The pathological changes are observed, while hematoxylin–eosin staining and picric acid Sirius red staining were conducted in successfully constructed myocarditis mouse models. Immunohistochemistry and enzyme‐linked immunosorbent assay were adopted to determine Ogn and β‐catenin levels and serum procollagen propeptide concentrations in the mouse myocardial tissues, respectively. Expression of Ogn and Wnt signaling pathway‐related factors were measured by reverse transcription quantitative polymerase chain reaction and western blot assay, cell viability by 3‐(4, 5‐Dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide assay, and cell cycle distribution and apoptosis by flow cytometry. We saw indicative pathological changes accompanied by many Ogn and β‐catenin positive cells and increased serum procollagen propeptide, in the mouse myocardial tissues. Loss function assays showed reduced levels of Ogn, β‐catenin, LRP6, TGF‐β1, Twist, FSP‐1, α‐SMA and higher levels of E‐cadherin and VE‐cadherin, together with decreased proliferation rate, as well as increased apoptosis rate, indicating that the Wnt signaling pathway, proliferation were inhibited while apoptosis was enhanced with upon gene silencing. Coherently, depletion of Ogn inhibits myocardial fibroblasts proliferation and EMT/EndMT while facilitating myocardial fibroblasts apoptosis in myocarditis through the Wnt signaling pathway, thus serving as an intervention target for the molecular treatment of myocarditis. … (more)
- Is Part Of:
- BioFactors. Volume 46:Number 6(2020)
- Journal:
- BioFactors
- Issue:
- Volume 46:Number 6(2020)
- Issue Display:
- Volume 46, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 46
- Issue:
- 6
- Issue Sort Value:
- 2020-0046-0006-0000
- Page Start:
- 1018
- Page End:
- 1030
- Publication Date:
- 2020-11-03
- Subjects:
- epithelial/endothelial‐mesenchymal transformation -- myocardial fibrosis -- myocarditis -- Ogn -- Wnt signaling pathway
Vitamins -- Physiological effect -- Periodicals
Trace elements -- Physiological effect -- Periodicals
Growth factors -- Physiological effect -- Periodicals
Plant growth promoting substances -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Nutritional Physiological Phenomena -- Periodicals
Trace Elements -- metabolism -- Periodicals
Vitamins -- metabolism -- Periodicals
Molecular Biology -- Periodicals
612.399 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1872-8081 ↗
http://search.epnet.com/direct.asp?jid=BFT&db=afh ↗
http://www.ebscohost.com ↗
http://www3.interscience.wiley.com/journal/121452383/ ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0951-6433;screen=info;ECOIP ↗ - DOI:
- 10.1002/biof.1683 ↗
- Languages:
- English
- ISSNs:
- 0951-6433
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2072.123000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15329.xml